Millipore Sigma Vibrant Logo

444284 MMP-2/MMP-3 Inhibitor III, PD166793 - CAS 199850-67-4 - Calbiochem

The MMP-2/MMP-3 Inhibitor III, PD166793, also referenced under CAS 199850-67-4, controls the biological activity of MMP-2/MMP-3. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: (S)-2-(4ʹ-Bromo-biphenyl-4-sulfonylamino-3-methylbutyric acid)

Primary Target: MMP-2, -3, and -13
View Products on Sigmaaldrich.com
444284
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
199850-67-4C₁₇H₁₈BrNO₄S

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
444284-5MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 5 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewA cell-permeable biphenylsulfonylvaline compound that acts as a potent inhibitor against MMP-2, -3, and -13 (IC50 = 47, 12, and 8 nM, respectively) and a weaker inhibitor against AMP deaminase (20% inhibition at 0.1 µM), MMP-1, -7, -9, and -14 (IC50 = 6.1, 7.2, 7.9, and 0.24 µM, respectively). Shown to offer therapeutic benefits in vivo in various animal models of heart failure and diabetes.
      Catalogue Number444284
      Brand Family Calbiochem®
      Synonyms(S)-2-(4ʹ-Bromo-biphenyl-4-sulfonylamino-3-methylbutyric acid)
      References
      ReferencesPaolocci, N., et al. 2006. J. Pharm. Exp. Ther. 317, 506.
      Zhou, Y.P., et al. 2005. Diabetes 54, 2612.
      Peterson, J.T., et al. 2001. Circulation 103, 2303.
      Spinale, F.G., et al. 1999. Circ. Res. 85, 364.
      Product Information
      CAS number199850-67-4
      ATP CompetitiveN
      FormOff-white solid
      Hill FormulaC₁₇H₁₈BrNO₄S
      Chemical formulaC₁₇H₁₈BrNO₄S
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetMMP-2, -3, and -13
      Primary Target IC<sub>50</sub>47, 12, and 8 nM, against MMP-2, -3, and -13, respectively
      Purity≥98% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      444284-5MG 04055977186017

      Documentation

      MMP-2/MMP-3 Inhibitor III, PD166793 - CAS 199850-67-4 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      MMP-2/MMP-3 Inhibitor III, PD166793 - CAS 199850-67-4 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      444284

      Referencias bibliográficas

      Visión general referencias
      Paolocci, N., et al. 2006. J. Pharm. Exp. Ther. 317, 506.
      Zhou, Y.P., et al. 2005. Diabetes 54, 2612.
      Peterson, J.T., et al. 2001. Circulation 103, 2303.
      Spinale, F.G., et al. 1999. Circ. Res. 85, 364.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision07-August-2008 RFH
      Synonyms(S)-2-(4ʹ-Bromo-biphenyl-4-sulfonylamino-3-methylbutyric acid)
      DescriptionA cell-permeable biphenylsulfonylvaline compound that acts as a potent inhibitor against MMP-2, -3, and -13 (IC50 = 47, 12, and 8 nM, respectively) and a weaker inhibitor against AMP deaminase (20% inhibition at 0.1 µM), MMP-1, -7, -9, and -14 (IC50 = 6.1, 7.2, 7.9, and 0.24 µM, respectively). Shown to offer therapeutic benefits in vivo in various animal models of heart failure and diabetes.
      FormOff-white solid
      CAS number199850-67-4
      Chemical formulaC₁₇H₁₈BrNO₄S
      Structure formulaStructure formula
      Purity≥98% by TLC
      SolubilityDMSO (40 mg/ml) or Ethanol (40 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Irritant
      ReferencesPaolocci, N., et al. 2006. J. Pharm. Exp. Ther. 317, 506.
      Zhou, Y.P., et al. 2005. Diabetes 54, 2612.
      Peterson, J.T., et al. 2001. Circulation 103, 2303.
      Spinale, F.G., et al. 1999. Circ. Res. 85, 364.